Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements), 2015, further to letter dated 28.09.2022, Vivimed Labs has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, 14th Day of November, 2022 at Hyderabad to consider and approve un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September, 2022. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has intimated its ‘Designated Persons including Directors’ regarding the closure of trading window from 01.10.2022 to till 48 hours after the declaration of un-audited Financial Results (Standalone & Consolidated) of the company for the quarter and half year ended 30th September, 2022.
The above information is a part of company’s filings submitted to BSE.
